Literature DB >> 8774511

Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin.

C Berger1, G E Pfyffer, D Nadal.   

Abstract

Treatment with clarithromycin plus rifabutin in children with nontuberculous mycobacterial lymphadenitis was associated with resolution of chronic sinus formation and discharge after incomplete excision in five of five cases, and involution of the enlarged lymph nodes in two of three cases treated without surgery.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8774511     DOI： 10.1016/s0022-3476(96)70288-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  7 in total

1.  Suppurative lymphadenitis.

Authors:  Iain P Fraser
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

Review 2.  Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.

Authors:  N Principi; S Esposito
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

3.  Atypical mycobacterial cervical lymphadenitis with extensive local spread: a surgical disease.

Authors:  M Hogan; D Price; K Burrage; C Pushpanathan
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

4.  Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children.

Authors:  E S Bruijnesteijn Van Coppenraet; J A Lindeboom; J M Prins; M F Peeters; E C J Claas; E J Kuijper
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

5.  Lymphadenopathy caused by Mycobacterium colombiense.

Authors:  Oscar Esparcia; Ferran Navarro; Miquel Quer; Pere Coll
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

6.  An unusual case of a cervical mass due to nontuberculous mycobacterium fortuitum infection.

Authors:  Hien Nguyen; Connie Le; Hanh Nguyen
Journal:  Perm J       Date:  2008

7.  Mycobacterium haemophilum and lymphadenitis in children.

Authors:  Lesla E S Bruijnesteijn van Coppenraet; Edward J Kuijper; Jerome A Lindeboom; Jan M Prins; Eric C J Claas
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.